Freshpet
FRPT Nasdaq Packaged Foods & Meats Financials FY2016βFY2025
Freshpet's revenue rose 13.0% to $1.1 billion in fiscal 2025. Its operating margin was 6.9%, up from 3.9% a year earlier. Free cash flow was $12 million. The diluted share count rose 11.5%.
What Freshpet does
No business description yet.
- Legal name
- FRESHPET, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001611647-26-000006
0001611647
Revenue and margins
Freshpet had $1.1B of revenue in fiscal 2025, up 13.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $12.4M in fiscal 2025, 1.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Freshpet returned $0.0M to shareholders in fiscal 2025, 0% of free cash flow. The diluted share count rose 11.5%.
Value Freshpet yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$150M and divides by 56.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 16.9x Β· peers 22.4x Β· sector 24.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Freshpet can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $72.8M | $153M | $297M | $269M | $278M |
| Debt incl. finance leases | $0.0M | $0.0M | $421M | $421M | $428M |
| Net debt / EBITDA | β15.2x | β | 4.5x | 1.4x | 0.9x |
| Debt / equity | 0.0x | 0.0x | 0.4x | 0.4x | 0.4x |
| Interest coverage | β8.6x | β10.0x | β2.2x | 3.1x | 5.4x |
| Current ratio | 2.6x | 2.9x | 4.8x | 4.4x | 5.5x |
| Quick ratio | 2.0x | 2.3x | 4.1x | 3.6x | 4.6x |
| Total assets | $784M | $1.1B | $1.5B | $1.6B | $1.8B |
| Total liabilities | $64.7M | $93.8M | $511M | $520M | $569M |
| Shareholders' equity | $720M | $1.0B | $954M | $1.1B | $1.2B |
| Net debt (β = net cash) | β$72.8M | β$153M | $124M | $152M | $150M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.2M
3 insiders
Sold, 12 months
$26.2M
1 insider
Of sales under plans
100%
$26.2M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Walter N. GeorgeDirector | Bought | 1,000 | $64.92 | $0.1M | Form 4 |
| Aug 26, 2026 | William B. CyrChief Executive Officer, Director | Sold plan | 39,664 | $74.72 | $3.0M | Form 4 |
| Aug 24, 2026 | William B. CyrChief Executive Officer, Director | Sold plan | 43,960 | $75.85 | $3.3M | Form 4 |
| Aug 21, 2026 | William B. CyrChief Executive Officer, Director | Sold plan | 43,945 | $73.90 | $3.2M | Form 4 |
| Aug 19, 2026 | William B. CyrChief Executive Officer, Director | Sold plan | 44,078 | $74.72 | $3.3M | Form 4 |
| Aug 17, 2026 | William B. CyrChief Executive Officer, Director | Sold plan | 44,067 | $72.83 | $3.2M | Form 4 |
| Aug 14, 2026 | William B. CyrChief Executive Officer, Director | Sold plan | 44,069 | $72.90 | $3.2M | Form 4 |
| May 22, 2026 | William B. CyrChief Executive Officer, Director | Sold plan | 46,814 | $51.04 | $2.4M | Form 4 |
| May 20, 2026 | Craig D. SteeneckDirector | Bought | 2,000 | $47.83 | $0.1M | Form 4 |
| May 20, 2026 | Daryl G BrewsterDirector | Bought | 211 | $47.52 | $0.0M | Form 4 |
| May 20, 2026 | William B. CyrChief Executive Officer, Director | Sold plan | 47,582 | $47.88 | $2.3M | Form 4 |
| May 18, 2026 | William B. CyrChief Executive Officer, Director | Sold plan | 47,181 | $49.01 | $2.3M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 9 | 6 / 9 | 8 / 9 |
| Accruals ratio | β8.5% | β7.1% | β1.3% |
| Altman Z'' | 2.60 | 3.12 | 3.57 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Freshpet FRPT | $3.6B | 13.0% | 6.9% | 1.1% | 5.9% | 16.9x | 8 | |
| John B. Sanfilippo & Son JBSS | $791M | 6.2% | 7.6% | 3.0% | 16.6% | 12.8x | 3 | Compare β |
| Simply Good Foods SMPL | $936M | 9.0% | 10.8% | 10.9% | 6.1% | β | 4 | Compare β |
| J&J Snack Foods JJSF | $1.6B | 0.5% | 5.3% | 5.2% | 7.3% | 32.1x | 4 | Compare β |
| Tootsie Roll Industries TR | $2.6B | 1.3% | 13.8% | 13.2% | β | β | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $130M | $152M | $193M | $246M | $319M | $426M | $595M | $767M | $975M | $1.1B |
| Gross profit | $60.4M | $72.4M | $90.0M | $114M | $133M | $162M | $186M | $251M | $396M | $450M |
| Research and development | $0.5M | $0.3M | $0.5M | $1.2M | $0.8M | β | β | β | β | β |
| Operating income | β$2.2M | β$2.8M | β$4.9M | β$0.3M | β$2.0M | β$24.7M | β$52.0M | β$30.4M | $38.0M | $75.7M |
| Interest expense | $0.7M | $0.9M | $0.3M | $1.0M | $1.2M | $2.9M | $5.2M | $14.1M | $12.3M | $14.1M |
| Pretax income | β$3.1M | β$4.2M | β$5.3M | β$1.2M | β$3.1M | β$27.5M | β$55.5M | β$31.5M | $47.5M | $70.8M |
| Income tax | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.2M | $0.3M | $0.2M | $0.6M | β$68.4M |
| Net income | β$3.2M | β$4.3M | β$5.4M | β$1.4M | β$3.2M | β$29.7M | β$59.5M | β$33.6M | $46.9M | $139M |
| Diluted EPS | β$0.09 | β$0.12 | β$0.15 | β$0.04 | β$0.08 | β$0.69 | β$1.29 | β$0.70 | $0.93 | $2.64 |
| Diluted shares | 0.03B | 0.03B | 0.04B | 0.04B | 0.04B | 0.04B | 0.05B | 0.05B | 0.05B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $12.8M | $10.3M | $18.6M | $16.3M | $21.2M | $0.6M | β$43.2M | $75.9M | $154M | $161M |
| Capital expenditure | $30.0M | $13.0M | $16.3M | $70.6M | $135M | $322M | $230M | $239M | $187M | $148M |
| Free cash flow | β$17.2M | β$2.7M | $2.3M | β$54.3M | β$113M | β$321M | β$273M | β$163M | β$32.8M | $12.4M |
| Depreciation and amortization | $9.9M | $12.7M | $13.8M | $15.6M | $20.8M | $29.5M | $34.3M | $58.2M | $69.5M | $86.4M |
| Stock-based compensation | $4.2M | $4.4M | $6.8M | $7.8M | $10.9M | $25.0M | $26.1M | $24.9M | $51.8M | $13.9M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.3M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $0.0M | $0.3M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | β | $2.2M | $7.6M | $9.5M | $67.2M | $72.8M | $153M | $297M | $269M | $278M |
| Total debt | β | β | β | $109M | β | $0.0M | $0.0M | $393M | $395M | $397M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $28.1M | $25.4M | $30.4M |
| Current assets | $19.2M | $27.0M | $31.0M | $54.3M | $109M | $150M | $262M | $427M | $437M | $436M |
| Current liabilities | $18.7M | $16.7M | $18.2M | $42.0M | $33.1M | $58.9M | $89.6M | $89.2M | $98.9M | $78.6M |
| Inventory | $5.4M | $10.1M | $9.3M | $12.5M | $19.1M | $35.6M | $58.3M | $63.2M | $80.8M | $76.8M |
| Property and equipment, net | $102M | $101M | $102M | $165M | $281M | $584M | $801M | $979M | $1.1B | $1.1B |
| Total assets | $127M | $134M | $140M | $236M | $434M | $784M | $1.1B | $1.5B | $1.6B | $1.8B |
| Total liabilities | $18.7M | $17.0M | $18.5M | $105M | $40.2M | $64.7M | $93.8M | $511M | $520M | $569M |
| Shareholders' equity | $108M | $117M | $122M | $131M | $394M | $720M | $1.0B | $954M | $1.1B | $1.2B |
| Margins | ||||||||||
| Gross margin | 46.5% | 47.5% | 46.6% | 46.5% | 41.7% | 38.1% | 31.3% | 32.7% | 40.6% | 40.8% |
| Operating margin | β1.7% | β1.8% | β2.5% | β0.1% | β0.6% | β5.8% | β8.7% | β4.0% | 3.9% | 6.9% |
| EBITDA margin | 5.9% | 6.5% | 4.6% | 6.2% | 5.9% | 1.1% | β3.0% | 3.6% | 11.0% | 14.7% |
| Net margin | β2.4% | β2.8% | β2.8% | β0.6% | β1.0% | β7.0% | β10.0% | β4.4% | 4.8% | 12.6% |
| FCF margin | β13.2% | β1.8% | 1.2% | β22.1% | β35.6% | β75.6% | β45.9% | β21.3% | β3.4% | 1.1% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | β | β5.4% | β2.5% | 3.3% | 5.9% |
| Return on capital employed | β2.1% | β2.5% | β4.1% | β0.2% | β0.7% | β4.4% | β5.9% | β2.5% | 2.7% | 4.8% |
| Return on equity | β3.0% | β3.8% | β4.5% | β1.1% | β1.2% | β5.3% | β6.8% | β3.4% | 4.7% | 12.3% |
| Return on assets | β2.6% | β3.3% | β3.9% | β0.7% | β1.0% | β4.9% | β6.2% | β2.6% | 3.1% | 8.3% |
| Growth | ||||||||||
| Revenue growth | 11.6% | 17.5% | 26.8% | 27.2% | 29.7% | 33.5% | 39.9% | 28.8% | 27.2% | 13.0% |
| Net income growth | β | β | β | β | β | β | β | β | β | 196.5% |
| EPS growth | β | β | β | β | β | β | β | β | β | 183.9% |
| FCF growth | β | β | β | β2,460.5% | β | β | β | β | β | β |
| Share count change | 0.5% | 2.4% | 2.4% | 1.8% | 10.6% | 8.0% | 7.6% | 4.3% | 4.3% | 11.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | 6.5x | β | β15.2x | β | 4.5x | 1.4x | 0.9x |
| Debt / equity | β | β | β | 0.8x | β | 0.0x | 0.0x | 0.4x | 0.4x | 0.4x |
| Interest coverage | β3.2x | β3.0x | β16.5x | β0.3x | β1.7x | β8.6x | β10.0x | β2.2x | 3.1x | 5.4x |
| Current ratio | 1.0x | 1.6x | 1.7x | 1.3x | 3.3x | 2.6x | 2.9x | 4.8x | 4.4x | 5.5x |
| Quick ratio | 0.7x | 1.0x | 1.2x | 1.0x | 2.7x | 2.0x | 2.3x | 4.1x | 3.6x | 4.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 23.1% | 8.5% | 8.4% | 28.7% | 42.2% | 75.7% | 38.7% | 31.2% | 19.2% | 13.5% |
| Stock comp / revenue | 3.2% | 2.9% | 3.5% | 3.2% | 3.4% | 5.9% | 4.4% | 3.3% | 5.3% | 1.3% |
| Payouts / FCF | β | β | 11.1% | β | β | β | β | β | β | 0.0% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | β | β | β | 2.0 | 5.0 | 6.0 | 8.0 |
| Altman Z'' | 1.0 | 2.8 | 2.6 | β1.2 | 9.9 | 11.3 | 11.4 | 2.6 | 3.1 | 3.6 |
| Accruals ratio | β13.3% | β11.2% | β17.5% | β9.4% | β7.3% | β5.0% | β1.7% | β8.5% | β7.1% | β1.3% |
Source: SEC EDGAR XBRL filings (CIK 0001611647). Data updated October 20, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.